Investing Profile
Wenwen He(5)
VC
Vice-President, Life Science Venture Capital Investor at Cathay Capital
New York, New York
Your Intro Paths to Wenwen He
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Wenwen is a member of
Mckinsey & Company Network
748 CONNECTIONS
McKinsey & Company Network
276 CONNECTIONS
INSEAD Network
231 CONNECTIONS
INSEAD Network
231 CONNECTIONS
Stealth Startup Network
182 CONNECTIONS
Current Investing Position
Cathay Capital Vice President
Investment Range
$5.0M - $15.0M
Sweet Spot
$10.0M
Wenwen He is on these Sector & Stage Rankings
Digital Health (Series B)Digital Health (Series A)Generative Tech/AI (Series B)Generative Tech/AI (Series A)Generative Tech/AI (Seed)Diverse InvestorsHealth & Hospital Services (Series B)Consumer Health (Series A)Health & Hospital Services (Series A)BioTech (Series B)SaaS (Series B)SaaS (Series A)Pharmaceuticals (Seed)Medical Devices (Seed)Health IT (Series B)Consumer Health (Series B)Pharmaceuticals (Series B)Health IT (Series A)Pharmaceuticals (Series A)Medical Devices (Series A)Medical Devices (Series B)Diagnostics (Seed)New York CityConsumer Health (Seed)Digital Health (Seed)BioTech (Series A)Diagnostics (Series B)BioTech (Seed)Health IT (Seed)Health & Hospital Services (Seed)SaaS (Seed)Diagnostics (Series A)Canada
Wenwen He's Experience
Leadership Program - Oncology NovartisPresent
Neurology & Pain Research Institut quantique - Université de SherbrookePresent
Solid Tumor Clinical Affairs Novartis OncologyPresent
Solid Tumor Medical Affairs Novartis OncologyPresent
Clinical Research - Neurology and Pain Université de SherbrookePresent
Solid Tumor Commercial Launch Novartis OncologyPresent
Chief of Staff, Sales & Marketing – Immunology & Established Brands Eli Lilly and CompanyPresent
Associate Manager, Immunology Sales & Marketing Integration Eli Lilly and CompanyPresent
Product Management, Hematology CelgenePresent
Commercial Leadership, Hematology CelgenePresent
Product Manager - Patient Services, Hematology CelgenePresent
Revlimid (Multiple Myeloma) - Product Leader CelgenePresent
Multiple Myeloma Commercial Lead CelgenePresent
Commercial Lead - Multiple Myeloma CelgenePresent
Business Development and Licensing, Cell Therapy Cytovia TherapeuticsPresent
Senior Management Consultant Mckinsey & CompanyPresent
Angel Investor Stealth StartupPresent
Advisor Stealth Mode BiotechPresent
Vice-President, Healthcare & Life Science Investments Cathay CapitalPresent
Vice-President, Life Science Venture Capital Investor Cathay CapitalPresent
Head of Market Access, Oncology & Hematology Portfolio and Pipeline — Intercontinental AbbViePresent
Sr. Management Consultant McKinsey & Company2022 - 2025
Commercial Lead Celgene2019 - 2020
Sales & Marketing, Chief of Staff Eli Lilly and Company2017 - 2019
Clinical & Medical Affairs Novartis2015 - 2017
Wenwen He's Education
Université de Sherbrooke Bachelor of Science (B.Sc.) Specialization in Pharmacology
INSEAD Master of Business Administration - MBA Strategy & Entrepreneurship
INSEAD Master of Business Administration - MBA
Sherbrooke University Bachelor of Science - B.Pharm Pharmacology
Investors who invest with Wenwen He
Sign in with Google →Scouts & Angels Affiliated With Wenwen He
Sign in with Google →